Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2017

View Archived Issues

AptaTargets raises funds to advance ApTOLL for acute ischemic stroke

Meaningful pain reduction seen with capsaicin formulation CNTX-4975 in Morton's neuroma

miR-21 a biomarker of visceral leishmaniasis vaccine immunogenicity

Corbin Therapeutics and Proteorex Therapeutics enter research and development collaboration

CHMP recommends approval of Insulin lispro Sanofi

GSK-2269557 effects evaluated in phase II COPD trial

Phase II results for cibinetide in patients with sarcoidosis-associated SNFL and neuropathic pain

Safety review committee approves continuation of Betalutin study

Erx Pharmaceuticals synthesizes novel celastrol derivatives

EMA validates application seeking expanded approval of Sprycel

EMA committee backs approval of Zykadia for first-line use in ALK+ NSCLC

Additional tolerability proof-of-concept data to be presented for KarXT

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

Chiesi's triple combination for the treatment of COPD receives positive opinion from EMA

Topline phase III data from active-comparator ARCH study of Evenity

MSD submits application in Japan for approval of combination drug for type 2 diabetes

Articular cartilage product granted positive opinion from CHMP for European approval

Trillium Therapeutics patents compounds for CNS disorders

Midatech selects preferred candidate for the treatment of glioblastoma

AstraZeneca enrolling patients in phase I trial of AZD-9898

Recordati to acquire European rights to AstraZeneca's metoprolol-based treatments

Cardioxane receives positive CHMP opinion in Europe

MAX BioPharma discovers new hedgehog and/or CTGF inhibitors

Heptares Therapeutics presents novel CGRP receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...